Robert S. Mannel

1994–2025 年に発表

81: 論文数
19,403: 被引用数
58: h 指数
75: i10 指数

被引用数

引用元

国・地域

0%23.4%その他 26.2%

機関

分野

トピック

全論文

並び替え

検索で開く

Recent advances and clinical applications of deep learning in medical image analysis
著者: Xuxin Chen, Ximin Wang, Ke Zhang, Roy Zhang, Kar-Ming Fung, Theresa C. Thai, Kathleen N. Moore, Robert S. Mannel, Hong Liu, Bin Zheng, Yuchen Qiu - Medical Image Analysis, Medical Image Anal. 2022 被引用: 1,010
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
著者: Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily Hinchcliff, Shashikant Lele, Lisa M. Landrum, Floor Backes, Roisin E. O’Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian - New England Journal of Medicine 2023 被引用: 701
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
著者: Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang - New England Journal of Medicine 2011 被引用: 2,384
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
著者: Robert L. Coleman, Mark F. Brady, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Joan L. Walker, Byoung‐Gie Kim, Keiichi Fujiwara, Krishnansu S. Tewari, David M. O’Malley, Susan A. Davidson, Stephen C. Rubin, Paul DiSilvestro, Karen Basen‐Engquist, Helen Huang, John K. Chan, Nick M. Spirtos, Raheela Ashfaq, Robert S. Mannel - The Lancet Oncology 2017 被引用: 602
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
著者: David S. Miller, Virginia L. Filiaci, Robert S. Mannel, David E. Cohn, Takashi Matsumoto, Krishnansu S. Tewari, Paul DiSilvestro, Michael L. Pearl, Peter A. Argenta, Matthew A. Powell, Susan Zweizig, David Warshal, Parviz Hanjani, Michael E. Carney, Helen Huang, David Cella, Richard J. Zaino, Gini F. Fleming - Journal of Clinical Oncology 2020 被引用: 340
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
著者: Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro, Barbara M. Norquist, Elizabeth M. Swisher, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Helen Huang, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Sharon X. Liang, Chenglin Ye, Carlos Bais, Leslie M. Randall, John K. Chan, J. Stuart Ferriss, Robert L. Coleman, Carol Aghajanian, Thomas J. Herzog, Philip J. DiSaia, Larry J. Copeland, Robert S. Mannel, Michael J. Birrer, Bradley J. Monk - Journal of Clinical Oncology 2019 被引用: 483
Inherited Mutations in Women With Ovarian Carcinoma
著者: Barbara M. Norquist, Maria I. Harrell, Mark F. Brady, Tom Walsh, Ming K. Lee, Süleyman Gülsüner, Sarah S. Bernards, Silvia Casadei, Yi Qian, Robert A. Burger, John K. Chan, Susan A. Davidson, Robert S. Mannel, Paul DiSilvestro, Heather A. Lankes, Nilsa C. Ramirez, Mary‐Claire King, Elizabeth M. Swisher, Michael J. Birrer - JAMA Oncology 2015 被引用: 764
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
著者: Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen - Journal of Clinical Oncology 2003 被引用: 2,055
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
著者: Robert L. Coleman, Nick M. Spirtos, Danielle Enserro, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Jae‐Weon Kim, Sang‐Yoon Park, Byoung‐Gie Kim, Joo-Hyun Nam, Keiichi Fujiwara, Joan L. Walker, A.Catherine Casey, Angeles Alvarez Secord, Steve Rubin, John K. Chan, Paul DiSilvestro, Susan A. Davidson, David E. Cohn, Krishnansu S. Tewari, Karen Basen‐Engquist, Helen Huang, Mark F. Brady, Robert S. Mannel - New England Journal of Medicine 2019 被引用: 334
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
著者: John Farley, William E. Brady, Vinod Vathipadiekal, Heather A. Lankes, Robert L. Coleman, Mark A. Morgan, Robert S. Mannel, S. Diane Yamada, David G. Mutch, William H. Rodgers, Michael J. Birrer, David M. Gershenson - The Lancet Oncology 2012 被引用: 413
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer
著者: Marcus E. Randall, Virginia L. Filiaci, D. Scott McMeekin, Vivian von Gruenigen, Helen Huang, Catheryn M. Yashar, Robert S. Mannel, Jae‐Weon Kim, Ritu Salani, Paul DiSilvestro, James J. Burke, Thomas Rutherford, Nick M. Spirtos, Keith Y. Terada, Penny R. Anderson, Wendy R. Brewster, William Small, Carol Aghajanian, David S. Miller - Journal of Clinical Oncology 2019 被引用: 328
Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2
著者: Joan L. Walker, Marion Piedmonte, Nick M. Spirtos, Scott M. Eisenkop, John B. Schlaerth, Robert S. Mannel, Gregory Spiegel, Richard R. Barakat, Michael L. Pearl, Sudarshan Sharma - Journal of Clinical Oncology 2009 被引用: 1,295
Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study
著者: Joan L. Walker, Marion R. Piedmonte, Nick M. Spirtos, Scott M. Eisenkop, John B. Schlaerth, Robert S. Mannel, Richard R. Barakat, Michael L. Pearl, Sudarshan Sharma - Journal of Clinical Oncology 2012 被引用: 778
MICU1 drives glycolysis and chemoresistance in ovarian cancer
著者: Prabir K. Chakraborty, Soumyajit Banerjee Mustafi, Xunhao Xiong, Shailendra Kumar Dhar Dwivedi, Vasyl Nesin, Sounik Saha, Min Zhang, Danny N. Dhanasekaran, Muralidharan Jayaraman, Robert S. Mannel, Kathleen N. Moore, Scott McMeekin, Da Yang, Rosemary E. Zuna, Kai Ding, Leonidas Tsiokas, Resham Bhattacharya, Priyabrata Mukherjee - Nature Communications 2017 被引用: 173
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
著者: Bradley J. Monk, Mark F. Brady, Carol Aghajanian, Heather A. Lankes, Tina Rizack, Joseph W. Leach, J.M. Fowler, Robert V. Higgins, P. Hanjani, Mark A. Morgan, Robert P. Edwards, William H. Bradley, Tatjana Kolevska, Periklis Foukas, E. Swisher, Karen S. Anderson, Raphaël Gottardo, J.K. Bryan, Mona Newkirk, Kristi L. Manjarrez, Robert S. Mannel, Robert M. Hershberg, George Coukos - Annals of Oncology 2017 被引用: 93
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study
著者: Benoît You, Christopher Purdy, Larry J. Copeland, Elizabeth M. Swisher, Michael A. Bookman, Gini F. Fleming, Robert L. Coleman, Leslie M. Randall, Krishnansu S. Tewari, Bradley J. Monk, Robert S. Mannel, Joan L. Walker, Fabio Cappuccini, David E. Cohn, Mahvish Muzaffar, David G. Mutch, Andrea E. Wahner Hendrickson, Lainie P. Martin, Olivier Colomban, Robert A. Burger - Journal of Clinical Oncology 2022 被引用: 75
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
著者: Barbara M. Norquist, Mark F. Brady, Maria I. Harrell, Tom Walsh, Ming K. Lee, Süleyman Gülsüner, Sarah S. Bernards, Silvia Casadei, Robert A. Burger, Krishnansu S. Tewari, Floor Backes, Robert S. Mannel, Gretchen Glaser, Cheryl L. Bailey, Stephen C. Rubin, John T. Soper, Heather A. Lankes, Nilsa C. Ramirez, Mary‐Claire King, Michael J. Birrer, Elizabeth M. Swisher - Clinical Cancer Research 2017 被引用: 235
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
著者: Joan L. Walker, Mark F. Brady, Lari Wenzel, Gini F. Fleming, Helen Huang, Paul DiSilvestro, Keiichi Fujiwara, David S. Alberts, Wenxin Zheng, Krishnansu S. Tewari, David E. Cohn, Matthew A. Powell, Linda Van Le, Susan A. Davidson, Heidi J. Gray, Peter G. Rose, Carol Aghajanian, Tashanna Myers, Angeles Alvarez Secord, Stephen C. Rubin, Robert S. Mannel - Journal of Clinical Oncology 2019 被引用: 232
Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses
著者: Carlos Bais, Barbara M. Mueller, Mark F. Brady, Robert S. Mannel, Robert A. Burger, Wei Wei, Koen M. Marien, Mark Kockx, Amreen Husain, Michael J. Birrer, NRG Oncology/Gynecologic Oncology Group - JNCI Journal of the National Cancer Institute 2017 被引用: 108
Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study
著者: Marcus E. Randall, Virginia L. Filiaci, Hyman B. Muss, Nick M. Spirtos, Robert S. Mannel, Jeffrey Fowler, J.T. Thigpen, J Bénda - Journal of Clinical Oncology 2005 被引用: 870
Randomized Double-Blind Trial of Estrogen Replacement Therapy Versus Placebo in Stage I or II Endometrial Cancer: A Gynecologic Oncology Group Study
著者: Richard R. Barakat, Brian N. Bundy, Nick M. Spirtos, Jeffrey G. Bell, Robert S. Mannel - Journal of Clinical Oncology 2006 被引用: 230
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
著者: Kate Oliver, William E. Brady, Michael J. Birrer, David M. Gershenson, Gini F. Fleming, Larry J. Copeland, Krishnansu S. Tewari, Peter A. Argenta, Robert S. Mannel, Angeles Alvarez Secord, Jean-Marie Stephan, David G. Mutch, Frederick B. Stehman, Franco M. Muggia, Peter G. Rose, Deborah K. Armstrong, Michael A. Bookman, Robert A. Burger, John Farley - Gynecologic Oncology 2017 被引用: 99
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218
著者: Angeles Alvarez Secord, Kirsten B. Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu, Mark D. Starr, John C. Brady, Heather A. Lankes, Herbert I. Hurwitz, Robert S. Mannel, Krishnansu S. Tewari, David M. O’Malley, Heidi J. Gray, Jamie N. Bakkum‐Gamez, Keiichi Fujiwara, Matthew Boente, Wei Deng, Robert A. Burger, Michael J. Birrer, Andrew B. Nixon - Clinical Cancer Research 2020 被引用: 57
LBA43 Updated response data and analysis of progression free survival by mechanism of mismatch repair loss in endometrial cancer (EC) patients (pts) treated with pembrolizumab plus carboplatin/paclitaxel (CP) as compared to CP plus placebo (PBO) in the NRG GY018 trial
著者: Ramez N. Eskander, Michael W. Sill, Austin Miller, Lucas R. Beffa, Richard G. Moore, Joanie Mayer Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, G. Canturia, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Erin Hinchcliff, Shashikant Lele, Matthew A. Powell, Carol Aghajanian - Annals of Oncology 2023 被引用: 19